How to Lower Your A1C Naturally and With Medication

Lowering your A1C involves reducing your average blood sugar over roughly two to three months, and the most effective strategies combine lifestyle changes with medication when needed. Diet, exercise, weight loss, and sleep all play measurable roles, while drugs like metformin, GLP-1 receptor agonists, and SGLT2 inhibitors can each shave off meaningful percentage points. The tricky part is that A1C responds to all of these inputs simultaneously, so what works best depends on where your numbers stand now and what is driving them up.

What A1C Actually Measures and Why It Matters

A1C reflects the percentage of your hemoglobin that has glucose stuck to it. Because red blood cells live for roughly 90 to 120 days, the test captures a rolling average of blood sugar rather than a snapshot. That is why a single good week does not move the needle much, but consistent changes compound over a couple of months. When your average blood sugar drops, less glucose attaches to fresh hemoglobin, and as older red blood cells die off and get replaced, your A1C follows.

One thing worth knowing is that anything affecting red blood cell lifespan can distort the reading. A shorter lifespan means hemoglobin has less time to collect glucose, pulling A1C artificially low even if your actual blood sugar has not changed.¹ Certain hemoglobin variants, common in people of African, Southeast Asian, or Mediterranean descent, can also throw off A1C results depending on the lab method used.² Iron deficiency anemia, for instance, can push A1C readings higher than they should be in people who do not even have diabetes, and the reading drops back down once the iron deficiency is treated.³ If your A1C seems oddly out of step with your fingerstick or continuous glucose monitoring data, ask your doctor whether something besides blood sugar could be affecting the number.

Dietary Changes That Move the Needle

Cutting carbohydrates is the single most studied dietary strategy for lowering A1C in type 2 diabetes. A meta-analysis of randomized trials found that low-carbohydrate diets reduced A1C by about 0.3 percentage points overall, with the strongest effect at the three-month mark, where tighter carbohydrate restriction correlated with larger drops in both A1C and weight.⁴ A separate systematic review found that at six months, more than half of people on low-carbohydrate diets hit an A1C below 6.5%, compared with about a third on control diets.⁵ The catch is that the effect tends to fade over time as adherence slips and metabolic adaptation sets in, so consistency matters more than perfection in the early weeks.

Fiber deserves its own mention because it works through a different pathway. Rather than simply removing carbs, high-fiber diets feed beneficial gut bacteria that produce short-chain fatty acids. A randomized clinical trial published in Science found that people with type 2 diabetes who ate a fiber-rich diet that promoted these specific bacteria saw better A1C improvements than a control group, partly because the bacteria stimulated more GLP-1 production, a hormone that helps regulate blood sugar.⁶ The broader research supports the idea that gut microbiota play a real role in glucose metabolism, and that dietary fiber is one of the most reliable ways to shift that microbial environment in a favorable direction.⁷

Intermittent fasting has also gathered evidence. A meta-analysis of studies in people with type 2 diabetes found that intermittent fasting reduced A1C in both people taking oral medications and those on insulin, with A1C drops averaging around half a percentage point in the oral-medication group and substantially more in people on insulin.⁸ Weight loss from fasting was not statistically significant in the pooled analysis, which suggests that at least some of the blood sugar improvement may come from altered meal timing and metabolic signaling rather than from losing weight alone. If you are on insulin or sulfonylureas, though, fasting regimens require careful medical supervision because of the risk of dangerously low blood sugar.

Exercise and the Power of Post-Meal Walking

Both aerobic exercise and resistance training lower A1C, and the difference between them is smaller than you might expect. A systematic review comparing the two found that aerobic exercise had a slight edge over resistance training in lowering A1C, but the difference was modest and became statistically unclear when the analysis was tightened.⁹ The practical takeaway is that the best type of exercise is whichever type you will actually do regularly. Combining both is ideal, but picking one and sticking with it beats switching between programs you abandon.

Timing, however, matters more than most people realize. A meta-analysis found that exercising after a meal reduced post-meal blood sugar spikes compared with both exercising before eating and doing nothing, while pre-meal exercise did not significantly lower post-meal glucose at all.¹⁰ Even a brief walk counts. A study measured what happened when people took just a ten-minute walk right after eating and found that both average blood sugar and peak glucose were meaningfully lower compared to staying seated, with the peak glucose dropping from about 182 to 164 mg/dL.¹¹ A crossover study in people with type 2 diabetes confirmed this in a real-world setting: walking specifically after meals lowered post-meal glucose more than the same total amount of walking done at a random time of day, and the benefit was strongest after dinner, when carbohydrate intake and sedentary behavior tend to peak.¹²

Those post-meal spikes accumulate into your A1C over weeks and months. Even if you are already exercising regularly, shifting some of that activity to the window right after eating can reduce the glucose peaks that drive your number up.

Weight Loss and A1C

Losing weight is one of the most potent levers for A1C. An analysis of U.S. national survey data found that losing more than 5% of body weight was linked to achieving an A1C below 6.5%.¹³ But the real surprise is how steeply the returns scale with the amount of weight lost. A systematic review and meta-regression found that for every one percentage point of body weight lost, the probability of complete diabetes remission increased by about two percentage points. At the extremes, only about 1% of people who lost less than 10% of body weight achieved complete remission at one year, compared with roughly half of those who lost 20 to 29% and nearly 80% of those who lost 30% or more.¹⁴

That does not mean modest weight loss is pointless. A 5 to 10% reduction still improves A1C in most people and brings other cardiovascular benefits. But it does explain why newer medications that cause significant weight loss, like GLP-1 and dual GLP-1/GIP agonists, produce some of the most dramatic A1C reductions seen in clinical trials.

Sleep, Stress, and Shift Work

Sleep is an underappreciated driver of blood sugar. When you sleep poorly, cortisol rises and insulin sensitivity drops. Cortisol directly promotes glucose production by the liver and can reduce insulin secretion by acting on the cells that make it.¹⁵ Sleep deprivation also raises ghrelin (which increases appetite), lowers leptin (which suppresses it), and impairs glucose metabolism broadly.¹⁶ In other words, bad sleep works against you from multiple angles at once: more hunger, worse insulin response, and more glucose dumped into your bloodstream.

Night shift work is a particularly clear example. A study of people with type 2 diabetes found that night-shift workers had a median A1C of about 7.9% compared to roughly 7.1 to 7.2% for day workers and unemployed participants, even after adjusting for body mass, insulin use, sleep duration, and diet.¹⁷ Another study found that both active and former night-shift workers had higher A1C and signs of circadian clock disruption compared with people who never worked nights, and that sleep quality was an independent driver of higher A1C levels.¹⁸ The disrupted sleep-wake cycle reduces insulin sensitivity and impairs glucose processing even in people who get enough total hours of sleep.¹⁹

If your schedule forces irregular sleep, prioritizing sleep hygiene on your off days, keeping meals on a consistent schedule, and being aggressive with the other levers discussed here becomes more important, not less.

Medications That Lower A1C

When lifestyle changes are not enough on their own, several classes of medication can bring A1C down substantially. The right choice depends on your starting A1C, other health conditions, risk of low blood sugar, and whether weight loss is a goal.

Metformin

Metformin remains the most widely prescribed first-line drug for type 2 diabetes. It works primarily by reducing how much glucose your liver produces.²⁰ Research has identified that it does this at least partly by inhibiting a key enzyme in the liver’s glucose-manufacturing pathway.²¹ It is cheap, well-tolerated by most people after the initial adjustment period, carries a low risk of causing low blood sugar, and is weight-neutral or slightly weight-reducing. Typical A1C reductions range from about 1 to 1.5 percentage points.

Sulfonylureas

Sulfonylureas stimulate the pancreas to produce more insulin regardless of your current blood sugar level, which makes them effective but riskier. A meta-analysis found that sulfonylurea monotherapy lowered A1C by about 1.5 percentage points more than placebo, with a similar drop when added to other oral drugs.²² The trade-off is a meaningfully higher rate of hypoglycemia and, in most people, weight gain. Higher doses did not produce bigger A1C reductions in the trials, so pushing the dose up is not the answer if you are already on one.

SGLT2 Inhibitors

SGLT2 inhibitors work in the kidneys rather than the pancreas or liver. They block a transporter that normally reabsorbs glucose from urine back into the bloodstream, so you literally excrete the extra sugar.²³ Beyond glucose control, this class also reduces blood pressure, protects kidney function over the long term by lowering pressure inside the kidney’s filtering units, and creates a mild metabolic state that may benefit the heart.²⁴ Typical A1C reductions are in the range of 0.5 to 0.8 percentage points, more modest than some other drugs, but the cardiovascular and kidney benefits make them a compelling add-on for many people.

GLP-1 and Dual GLP-1/GIP Agonists

Incretin-based injectable medications like semaglutide and tirzepatide are the most powerful A1C-lowering drugs currently available, in part because they simultaneously reduce appetite and cause significant weight loss. In a phase 2 trial of tirzepatide, the highest dose reduced A1C by 2.4 percentage points from a starting point of 8%, with body weight dropping by over 11 kg.²⁵ These drugs work by mimicking gut hormones that tell the pancreas to release insulin when blood sugar is high, slow stomach emptying, and signal satiety to the brain. Because the insulin release is glucose-dependent, the risk of hypoglycemia is low unless combined with insulin or sulfonylureas.

DPP-4 Inhibitors

DPP-4 inhibitors work on the same incretin system but from a different angle: instead of mimicking the gut hormones, they slow the breakdown of the hormones your body already makes. This produces a milder effect than the injectable GLP-1 drugs, with typical A1C reductions of about 0.5 to 0.8 percentage points. Their main appeal is convenience and a good safety profile with low hypoglycemia risk.²⁶

Insulin

When oral drugs and non-insulin injectables are not enough, insulin therapy can bring even very high A1C values down. A study of people with type 2 diabetes who were poorly controlled on other insulin regimens found that switching to a basal-bolus approach dropped A1C from an average of 9% to 8.1% within three months and to 8.0% at six months, cutting the proportion of patients with A1C above 9% from about half to roughly 14%.²⁷ Insulin’s biggest drawbacks are weight gain, the need for injections, and the risk of hypoglycemia, which require careful dose adjustments.

Supplements Worth Mentioning

Most supplements marketed for blood sugar have thin evidence behind them, but berberine stands out. A trial in people with type 2 diabetes found that berberine alone reduced A1C from 9.5% to 7.5% over the study period, with another arm showing a drop from 8.1% to 7.3%.²⁸ A more recent randomized trial found that combining berberine with cinnamon produced significantly lower fasting blood sugar and A1C compared to placebo.²⁹ Berberine is not a substitute for diabetes medication, and it can interact with other drugs, particularly metformin. But the evidence base is stronger than for most over-the-counter options, and it is worth discussing with your doctor if you are looking for an add-on.

How to Track Progress Beyond A1C

A1C is the standard metric, but it has blind spots. Because it is an average, it cannot distinguish between someone whose blood sugar is stable at 150 mg/dL all day and someone who swings between 70 and 250 but lands at the same average. Continuous glucose monitors address this by tracking blood sugar in real time and generating a metric called “time in range,” which measures the percentage of the day your glucose stays between 70 and 180 mg/dL. On average, spending about 70% of the day in that range corresponds to an A1C of roughly 7%, while 50% time in range corresponds to about 8%.³⁰

That said, the relationship between time in range and A1C is not perfectly tight. In people with highly variable glucose levels, time in range can bounce around a lot even when A1C stays stable.³¹ An international consensus now recommends using both metrics together, with specific targets for time in range, time below range (hypoglycemia), and time above range for different populations.³² CGM data can also complement A1C in populations where the A1C reading itself may be unreliable, such as older adults, people on insulin or sulfonylureas, and those with kidney disease.³³

The practical value of CGM for lowering A1C is that it reveals which meals spike you, whether your post-dinner walk is working, and how your body responds overnight. That real-time feedback loop is often what turns abstract advice into specific, actionable adjustments. Research has shown that time in range, when paired with a single calibration A1C measurement, can accurately approximate future A1C values for at least six months, meaning the two measures genuinely reflect the same underlying process and can be used interchangeably with proper setup.³⁴

1
PubMed Central. The influence of shorter red blood cell lifespan on the rate of HbA1c target achieved in type 2 diabetes patients with a HbA1c detection value lower than 7%
2
PubMed Central. Effects of hemoglobin variants on hemoglobin a1c values measured using a high-performance liquid chromatography method
3
PubMed Central. The effect of different types of anemia on HbA1c levels in non-diabetics
4
PubMed. Effectiveness of low-carbohydrate diets on type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials in Eastern vs. Western populations
5
BMJ. Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data
6
PubMed. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes
7
PubMed Central. The relationship between gut microbiota, short-chain fatty acids and type 2 diabetes mellitus: the possible role of dietary fibre
8
PubMed Central. Effects of intermittent fasting on HbA1c and weight in insulin versus oral hypoglycemic therapy-treated patients with type 2 diabetes mellitus: a systematic review and meta-analysis
9
PubMed. Resistance exercise versus aerobic exercise for type 2 diabetes: a systematic review and meta-analysis
10
PubMed Central. After Dinner Rest a While, After Supper Walk a Mile? A Systematic Review with Meta-analysis on the Acute Postprandial Glycemic Response to Exercise Before and After Meal Ingestion in Healthy Subjects and Patients with Impaired Glucose Tolerance
11
PubMed Central. Positive impact of a 10-min walk immediately after glucose intake on postprandial glucose levels
12
PubMed. Advice to walk after meals is more effective for lowering postprandial glycaemia in type 2 diabetes mellitus than advice that does not specify timing: a randomised crossover study
13
The Egyptian Journal of Internal Medicine. Association between weight loss and HbA1c management in patients with diabetes: a NHANES analysis
14
The Lancet Diabetes & Endocrinology. Bodyweight loss and type 2 diabetes remission: a systematic review and meta-regression analysis
15
PubMed Central. The relationship between sleep problems and cortisol in people with type 2 diabetes
16
PubMed Central. Metabolic, endocrine, and immune consequences of sleep deprivation
17
PubMed. Night-shift work is associated with poorer glycaemic control in patients with type 2 diabetes
18
PubMed Central. Alterations in Rev-ERBα/BMAL1 ratio and glycated hemoglobin in rotating shift workers: the EuRhythDia study
19
PubMed Central. Unraveling the complex relationship between night shift work and diabetes: exploring mechanisms and potential interventions
20
PubMed Central. The mechanisms of action of metformin
21
PubMed Central. Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase
22
PubMed. Estimating the effect of sulfonylurea on HbA1c in diabetes: a systematic review and meta-analysis
23
PubMed. Antihypertensive and Renal Mechanisms of SGLT2 (Sodium-Glucose Linked Transporter 2) Inhibitors
24
American Journal of Hypertension. State-of-the-Art-Review: Mechanisms of Action of SGLT2 Inhibitors and Clinical Implications
25
PubMed Central. The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials
26
Nature Reviews Endocrinology. Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus
27
Endocrinología y Nutrición (English Edition). Switching to basal-bolus insulin therapy is effective and safe in long-term type 2 diabetes patients inadequately controlled with other insulin regimens
28
PubMed Central. Efficacy of berberine in patients with type 2 diabetes mellitus
29
PubMed. The efficacy and safety of berberine in combination with cinnamon supplementation in patients with type 2 diabetes: a randomized clinical trial
30
PubMed Central. The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c
31
PubMed Central. Time in range—A new gold standard in type 2 diabetes research?
32
PubMed Central. Expert Recommendations for Using Time-in-Range and Other Continuous Glucose Monitoring Metrics to Achieve Patient-Centered Glycemic Control in People With Diabetes
33
The Journal of Clinical Endocrinology & Metabolism. The Importance of Continuous Glucose Monitoring-derived Metrics Beyond HbA1c for Optimal Individualized Glycemic Control
34
PubMed Central. Estimation of Hemoglobin A1c from Continuous Glucose Monitoring Data in Individuals with Type 1 Diabetes: Is Time In Range All We Need?